Soy seed dry extract 100 mg
Product Description
Biofarm Sp. z o.o.
-
Country/Region:Poland
-
On CPHI since:2015
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
Biofarm Sp. z o.o.
-
Country/Region:Poland
-
On CPHI since:2015
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
More Products from Biofarm Sp. z o.o. (38)
-
Product Donepezil hydrochloride 5 mg, 10 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes cogiton odt. Therapeutic category: neurology. Api + strength: donepezil hydrochloride 5, 10 mg. Form: orodispersible tablets. Contact us for more information. -
Product Cinnarizine 20 mg + Dimenhydrinate 40 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes artigo. Therapeutic category: neurology. Api + strength: cinnarizine 20 mg + dimenhydrinate 40 mg Form: film-coated tablets. Indication: vertigo. Contact us for more information. -
Product Ginkgo biloba leaf dry extract 40 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes ginkofar. Therapeutic category: neurology. Api + strength: ginkgo biloba leaf dry extract 40 mg. Form: film-coated tablets. Indication: difficult mental concentration, memory problems, dizziness, headaches, tinnitus, weakening... -
Product Ginkgo biloba leaf dry extract 80 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes ginkofar forte. Therapeutic category: neurology. Api + strength: ginkgo biloba leaf dry extract 80 mg. Form: film-coated tablets. Contact us for more information. -
Product Ginkgo biloba leaf dry extract 120 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes ginkofar max. Therapeutic category: neurology. Api + strength: ginkgo biloba leaf dry extract 120 mg. Form: film-coated tablets. Contact us for more information. -
Product Ginkgo biloba leaf dry extract 240 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes ginkofar extra. Therapeutic category: neurology. Api + strength: ginkgo biloba leaf dry extract 240 mg. Form: film-coated tablets. Indication: difficult mental concentration, memory problems, dizziness, headaches, tinnitus, we... -
Product Soy seed dry extract 230.8 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes soyfem forte. Therapeutic category: gynecology. Api + strength: soy seed dry extract 230.8 mg (corresponds to 60 mg of genistein). Form: film-coated tablets. Contact us for more information. -
Product Meloxicam 7.5 mg, 15 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes aspicam. Therapeutic category: painkillers. Api + strength: meloxicam 7.5, 15 mg. Form: tablets. Indication: arthritis. Contact us for more information. -
Product Magnesium citrate 500 mg, pirydoxini hydrochloridum 0.5 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes magnefar b6. Therapeutic category: dietary supplements. Api + strength: magnesium citrate 500 mg, pirydoxini hydrochloridum 0.5 mg. Form: tablets. Indication: exposure to stress, magnesium supplementation. Contact us for more ... -
Product Magnesium citrate 1096.5 mg, pyridoxini hydrochloridum 2 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes magnefar max. Therapeutic category: dietary supplements. Api + strength: magnesium citrate 1096.5 mg, pyridoxini hydrochloridum 10 mg . Form: fluid. tablets: recommended especially forexposure to stress, magnesium supplementat... -
Product Biotin 5 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes Biotynox . Biotin 5 mg, Indication: Strengthens hair, nails and skin. Contact us for more information. -
Product Biotin 10 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes Biotynox Forte. Biotin 10 mg, Indication: Strengthens hair, nails and skin. Contact us for more information.
Biofarm Sp. z o.o. resources (1)
-
Brochure Portfolio 2025
Portfolio 2025
